Skip to main content

26-03-2024 | Alzheimer's Disease | News

Do blood-based biomarkers diagnose AD or just inform on an individual’s risk?

Author: Lucy Piper

medwireNews: Blood-based biomarkers are a useful tool for stratifying an individual’s risk for Alzheimer’s disease (AD) in the early stages of cognitive decline, but do they actually “diagnose” AD in the truest sense?

Related topics